Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.070 | 0.571 | 7 | 2016 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.070 | 0.571 | 7 | 2016 | 2018 | |||||
Breast Carcinoma
|
2793 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.030 | 1.000 | 3 | 2017 | 2018 | |||||
Malignant neoplasm of breast
|
3417 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.030 | 1.000 | 3 | 2017 | 2018 | |||||
Carcinoma of lung
|
1204 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.020 | 0.500 | 2 | 2018 | 2018 | |||||
Malignant neoplasm of lung
|
1142 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.020 | 0.500 | 2 | 2018 | 2018 | |||||
Primary malignant neoplasm of lung
|
981 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.020 | 0.500 | 2 | 2018 | 2018 | |||||
Benign Prostatic Hyperplasia
|
91 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Central neuroblastoma
|
231 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
cervical cancer
|
268 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Cervix carcinoma
|
283 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Neuroblastoma
|
231 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of ovary
|
315 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of prostate
|
1082 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Malignant tumor of cervix
|
245 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Neuroblastoma
|
386 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
ovarian neoplasm
|
757 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Prostate carcinoma
|
1168 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Small cell carcinoma of lung
|
125 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Squamous cell carcinoma
|
257 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Uterine Fibroids
|
154 | 0.683 | 0.280 | 12 | 53967210 | intron variant | C/A | snv | 0.28 | 0.010 | 1 | 2019 | 2019 |